Skip to main content
SpringerLink
Log in

Varenicline: potential alcohol interaction, risk of seizures

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • FDA. FDA Drug Safety Communication: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking. Internet Document : 9 Mar 2015. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm436494.htm

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varenicline: potential alcohol interaction, risk of seizures. Reactions Weekly 1543, 7 (2015). https://doi.org/10.1007/s40278-015-8631-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8631-3

Search

Navigation